PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0024117|chronic obstructive pulmonary disease |
| Sentences | 33 |
| PubMedID- 23855769 | Adenosine a2b receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 24015329 | [153] in a recent study, eight patients with pulmonary hypertension associated with chronic obstructive pulmonary disease were daily treated with 200 mg of dhea. |
| PubMedID- 22333502 | Objective: the levels of c-reactive protein (crp), tumor necrosis factor (tnf)-alpha, brain natriuretic peptide (bnp) and endothelin-1 (et-1) were investigated to analyze the systemic inflammation in chronic obstructive pulmonary disease (copd) patients with and without pulmonary hypertension. |
| PubMedID- 26277885 | Background: there is no recommendation for treating pulmonary hypertension (ph) when associated with chronic obstructive pulmonary disease (copd). |
| PubMedID- 23945337 | [pulmonary hypertension in chronic obstructive pulmonary disease can not be ignored]. |
| PubMedID- 23744170 | pulmonary hypertension in chronic obstructive pulmonary disease. |
| PubMedID- 20819757 | The incidence and clinical course of pulmonary hypertension associated with chronic obstructive pulmonary disease is best known among the pulmonary hypertension associated with lung diseases. |
| PubMedID- 26453478 | Potential role of ct metrics in chronic obstructive pulmonary disease with pulmonary hypertension. |
| PubMedID- 24312428 | This model is clinically relevant, since chronic hypoxia is one of the major causes of sustained pulmonary hypertension in patients with advanced chronic obstructive pulmonary disease [15]. |
| PubMedID- 25176971 | The loss of pulmonary vessels has been shown to be related to the severity of pulmonary hypertension in patients with chronic obstructive pulmonary disease (copd). |
| PubMedID- 25469102 | Objective: this study strived to evaluate the relationship between degree of pulmonary emphysema and cardiac ventricular function in chronic obstructive pulmonary disease (copd) patients with pulmonary hypertension (ph) using electrocardiographic-gated multidetector computed tomography (ct). |
| PubMedID- 26064044 | Conclusion: despite the high rate of positivity for avt in severe pulmonary hypertension patients with chronic obstructive pulmonary disease, none of the variables under investigation displayed a noteworthy difference between avt negative and positive groups. |
| PubMedID- 22502811 | Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review. |
| PubMedID- 26064454 | Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 21575307 | Background: chronic obstructive pulmonary disease (copd) can lead to pulmonary hypertension and cor pulmonale, which are predictors of mortality. |
| PubMedID- 25708588 | Cigarette smoking contributes to the development of pulmonary hypertension (ph) complicated with chronic obstructive pulmonary disease (copd), and the pulmonary vascular remodeling, the structural basis of ph, could be attributed to abnormal proliferation of pulmonary artery smooth muscle cells (pasmcs).in this study, morphometrical analysis showed that the pulmonary vessel wall thickness in smoker group and copd group was significantly greater than in nonsmokers. |
| PubMedID- 20364612 | pulmonary hypertension associated with chronic obstructive pulmonary disease. |
| PubMedID- 22280813 | Dehydroepiandrosterone (dhea) improves pulmonary hypertension in chronic obstructive pulmonary disease (copd): a pilot study. |
| PubMedID- 26079807 | Cigarette smoke exposure is thought to be the most important trigger of pulmonary hypertension in chronic obstructive pulmonary disease [10]. |
| PubMedID- 19875683 | Rationale: vascular alteration of small pulmonary vessels is one of the characteristic features of pulmonary hypertension in chronic obstructive pulmonary disease. |
| PubMedID- 25225149 | Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. |
| PubMedID- 23018917 | The phenotype and outcome of severe pulmonary hypertension in chronic obstructive pulmonary disease (copd) is described in small numbers, and predictors of survival are unknown. |
| PubMedID- 21814783 | Study objectives: the etiology and prevalence of pulmonary hypertension (ph) in patients with stable chronic obstructive pulmonary disease (copd) is uncertain. |
| PubMedID- 25922708 | Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis. |
| PubMedID- 26361668 | pulmonary hypertension in chronic obstructive pulmonary disease and pulmonary fibrosis: prevalence and hemodynamic differences in lung transplant recipients at transplant center's referral time. |
| PubMedID- 26492415 | Background: patients with severe pulmonary hypertension (ph) associated with chronic obstructive pulmonary disease (copd) present a poor outcome. |
| PubMedID- 24578830 | Background: since pulmonary hypertension (ph) in patients with chronic obstructive pulmonary diseases (copd) causes poor prognosis and inflammatory process involved in ph, it is supposed that statins with anti-inflammatory effects might be useful in the treatment of ph. |
| PubMedID- 20865576 | [update on pulmonary hypertension in chronic obstructive pulmonary disease]. |
| PubMedID- 22001462 | Severe pulmonary hypertension in chronic obstructive pulmonary disease (copd) is referred to as 'disproportionate' because the elevated pulmonary artery pressure does not match the degree of air flow limitation. |
| PubMedID- 22839713 | [association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease]. |
| PubMedID- 25050435 | Conclusion: the current study reveals correlations between sst2 levels and echocardiographic parameters of rv dysfunction, suggesting that use of sst2 and nt-probnp may improve diagnosis and risk stratification in patients with secondary pulmonary hypertension owing to chronic obstructive pulmonary disease. |
| PubMedID- 24228853 | Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. |
| PubMedID- 23549775 | This case study presents a 44-year old man with chronic obstructive pulmonary disease and "out of proportion" pulmonary hypertension. |
Page: 1